» Articles » PMID: 17372613

Roles of CREB-binding Protein (CBP)/p300 in Respiratory Epithelium Tumorigenesis

Overview
Journal Cell Res
Specialty Cell Biology
Date 2007 Mar 21
PMID 17372613
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

CREB-binding protein (CBP) and its homologue p300 are transcriptional co-activators of various sequence-specific transcription factors that are involved in a wide array of cellular activities, such as DNA repair, cell growth, differentiation and apoptosis. Several studies have suggested that CBP and p300 might be considered as tumour suppressors, with their prominent role being the cross-coupling of distinct gene expression patterns in response to various stimuli. They exert their actions mainly via acetylation of histones and other regulatory proteins (e.g. p53). A major paradox in CBP/p300 function is that they seem capable of contributing to various opposed cellular processes. Respiratory epithelium tumorigenesis represents a complex process of multi-step accumulations of a gamut of genetic and epigenetic aberrations. Transcription modulation through the alternate formation of activating and repressive complexes is the ultimate converging point of these derangements, and CBP/p300 represents key participants in this interplay. Thus, illumination of their molecular actions and interactions could reveal new potential targets for pharmacological interventions in respiratory epithelium carcinogenesis.

Citing Articles

Exploring the role of CITED transcriptional regulators in the control of macrophage polarization.

Wiggins D, Maxwell J, Nelson D Front Immunol. 2024; 15:1365718.

PMID: 38646545 PMC: 11032013. DOI: 10.3389/fimmu.2024.1365718.


Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.

Song B, Yang P, Zhang S Cancer Commun (Lond). 2024; 44(3):297-360.

PMID: 38311377 PMC: 10958678. DOI: 10.1002/cac2.12520.


Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology.

Rabaan A, Aljeldah M, Al Shammari B, Alsubki R, Alotaibi J, Alhashem Y Microorganisms. 2023; 11(2).

PMID: 36838306 PMC: 9967649. DOI: 10.3390/microorganisms11020341.


FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Li Z, Shi J, Zhang N, Zheng X, Jin Y, Wen S J Cancer. 2022; 13(8):2528-2539.

PMID: 35711849 PMC: 9174856. DOI: 10.7150/jca.67977.


Identification of novel alternative splicing associated with mastitis disease in Holstein dairy cows using large gap read mapping.

Asselstine V, Medrano J, Canovas A BMC Genomics. 2022; 23(1):222.

PMID: 35305573 PMC: 8934477. DOI: 10.1186/s12864-022-08430-x.